Ethics of medication-free research in schizophrenia.
作者信息
Chen Donna T, Moreno Jonathan D
机构信息
Department of Public Health Sciences, Charlottesville, VA, USA.
出版信息
Schizophr Bull. 2006 Apr;32(2):307-9. doi: 10.1093/schbul/sbj049. Epub 2006 Feb 8.
Abstract
摘要
相似文献
1
Ethics of medication-free research in schizophrenia.精神分裂症无药物治疗研究的伦理问题。
Schizophr Bull. 2006 Apr;32(2):307-9. doi: 10.1093/schbul/sbj049. Epub 2006 Feb 8.
2
Withholding proven treatment in research.
N Engl J Med. 2002 Feb 7;346(6):455-6. doi: 10.1056/NEJM200202073460618.
3
Can medication-free research ever be ethical in older people with psychotic disorders?对于患有精神障碍的老年人，无药物研究能符合伦理道德吗？
Schizophr Bull. 2006 Apr;32(2):303-4. doi: 10.1093/schbul/sbj047. Epub 2006 Feb 9.
4
Medication-free research in early episode schizophrenia: why on earth would I choose to participate in such research?首发精神分裂症的无药物治疗研究：我究竟为何要选择参与此类研究？
Schizophr Bull. 2006 Apr;32(2):305-6. doi: 10.1093/schbul/sbj057. Epub 2006 Feb 15.
5
The withholding of test results as a means of assessing the effectiveness of treatment in test-positive persons.将检测结果作为评估治疗效果的手段，用于检测阳性者。
J Clin Epidemiol. 2013 Apr;66(4):355-8. doi: 10.1016/j.jclinepi.2012.07.011. Epub 2012 Sep 13.
6
Ethics, healthcare and spinal cord injury: research, practice and finance.伦理、医疗保健与脊髓损伤：研究、实践与财务
Spinal Cord. 2011 Feb;49(2):161. doi: 10.1038/sc.2010.195.
7
Implications for future research of "medication-free research in early episode schizophrenia".“首发精神分裂症无药物研究”对未来研究的启示
Schizophr Bull. 2006 Apr;32(2):297-8. doi: 10.1093/schbul/sbj060. Epub 2006 Feb 15.
8
Between madness and death: the medicate-to-execute controversy.介于疯狂与死亡之间：药物执行死刑的争议
Crim Justice Ethics. 2003 Summer-Fall;22(2):3-14. doi: 10.1080/0731129X.2003.9992146.
9
The ethics of using scientific data obtained by immoral means.
N Y State J Med. 1991 Feb;91(2):54-9.
10
The ethics of withdrawing treatment: how should the choice be made?
Am J Hosp Palliat Care. 2006 Jun-Jul;23(3):170-2. doi: 10.1177/1049909106289354.
引用本文的文献
1
"We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry.“我们需要非常审慎且细致地部署它们”：美国艾滋病治愈研究中对分析性治疗中断的认知——一项定性调查
AIDS Res Hum Retroviruses. 2018 Jan;34(1):67-79. doi: 10.1089/AID.2017.0067. Epub 2017 Jul 10.
2
The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.在病情稳定的精神分裂症患者中使用持续治疗与安慰剂或间歇治疗策略：对使用第一代和第二代抗精神病药物的随机对照试验的系统评价和荟萃分析
CNS Drugs. 2015 Aug;29(8):637-58. doi: 10.1007/s40263-015-0269-4.
本文引用的文献
1
Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.抗精神病药物安慰剂对照和活性对照临床试验中的脱落率：一项荟萃分析。
Arch Gen Psychiatry. 2005 Dec;62(12):1305-12. doi: 10.1001/archpsyc.62.12.1305.
2
Medication-free research in early episode schizophrenia: evidence of long-term harm?首发精神分裂症的无药治疗研究：长期危害的证据？
Schizophr Bull. 2006 Apr;32(2):288-96. doi: 10.1093/schbul/sbj019. Epub 2005 Oct 27.
3
Emerging empirical evidence on the ethics of schizophrenia research.关于精神分裂症研究伦理的新实证证据。
Schizophr Bull. 2006 Jan;32(1):47-68. doi: 10.1093/schbul/sbj012. Epub 2005 Oct 19.
4
Consensus and controversy in clinical research ethics.临床研究伦理中的共识与争议。
JAMA. 2005 Sep 21;294(11):1411-4. doi: 10.1001/jama.294.11.1411.
5
Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.精神分裂症随机非典型抗精神病药物试验中的对照组偏倚。
Arch Gen Psychiatry. 2005 Sep;62(9):961-70. doi: 10.1001/archpsyc.62.9.961.
6
The ethics of placebo-controlled trials--a middle ground.安慰剂对照试验的伦理学——一种折衷方案。
N Engl J Med. 2001 Sep 20;345(12):915-9. doi: 10.1056/NEJM200109203451211.
7
The rationale and ethics of medication-free research in schizophrenia.精神分裂症无药物治疗研究的基本原理与伦理
Arch Gen Psychiatry. 1997 May;54(5):401-7. doi: 10.1001/archpsyc.1997.01830170015002.
Zotero 插件